These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 15986142

  • 1. Rb/E2F: a two-edged sword in the melanocytic system.
    Halaban R.
    Cancer Metastasis Rev; 2005 Jun; 24(2):339-56. PubMed ID: 15986142
    [Abstract] [Full Text] [Related]

  • 2. Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1E132, but not by deletion of p16INK4A or p21WAF1/CIP1.
    Halaban R, Cheng E, Zhang Y, Mandigo CE, Miglarese MR.
    Oncogene; 1998 May 14; 16(19):2489-501. PubMed ID: 9627115
    [Abstract] [Full Text] [Related]

  • 3. Unbiased analysis of RB-mediated transcriptional repression identifies novel targets and distinctions from E2F action.
    Markey MP, Angus SP, Strobeck MW, Williams SL, Gunawardena RW, Aronow BJ, Knudsen ES.
    Cancer Res; 2002 Nov 15; 62(22):6587-97. PubMed ID: 12438254
    [Abstract] [Full Text] [Related]

  • 4. Rb dephosphorylation and suppression of E2F activity in human breast tumor cells exposed to a pharmacological concentration of estradiol.
    Gewirtz DA, Di YM, Randolph JK, Jain PT, Valerie K, Bullock S, Nath N, Chellappan SP.
    Arch Biochem Biophys; 2001 Apr 15; 388(2):243-52. PubMed ID: 11368161
    [Abstract] [Full Text] [Related]

  • 5. Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells.
    Davis JN, McCabe MT, Hayward SW, Park JM, Day ML.
    Cancer Res; 2005 May 01; 65(9):3633-42. PubMed ID: 15867358
    [Abstract] [Full Text] [Related]

  • 6. Differential regulation of apoptotic genes by Rb in human versus mouse cells.
    Young AP, Longmore GD.
    Oncogene; 2004 Apr 08; 23(15):2587-99. PubMed ID: 15048095
    [Abstract] [Full Text] [Related]

  • 7. Bone morphogenetic protein-2 induces hypophosphorylation of Rb protein and repression of E2F in androgen-treated LNCaP human prostate cancer cells.
    Tomari K, Kumagai T, Shimizu T, Takeda K.
    Int J Mol Med; 2005 Feb 08; 15(2):253-8. PubMed ID: 15647840
    [Abstract] [Full Text] [Related]

  • 8. Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway.
    McCabe MT, Davis JN, Day ML.
    Cancer Res; 2005 May 01; 65(9):3624-32. PubMed ID: 15867357
    [Abstract] [Full Text] [Related]

  • 9. Abnormal cell cycle regulation in primary human uveal melanoma cultures.
    Pardo M, Piñeiro A, de la Fuente M, García A, Prabhakar S, Zitzmann N, Dwek RA, Sánchez-Salorio M, Domínguez F, Capeans C.
    J Cell Biochem; 2004 Nov 01; 93(4):708-20. PubMed ID: 15660415
    [Abstract] [Full Text] [Related]

  • 10. The Rb/chromatin connection and epigenetic control: opinion.
    Ferreira R, Naguibneva I, Pritchard LL, Ait-Si-Ali S, Harel-Bellan A.
    Oncogene; 2001 May 28; 20(24):3128-33. PubMed ID: 11420729
    [Abstract] [Full Text] [Related]

  • 11. Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes.
    Bandyopadhyay D, Okan NA, Bales E, Nascimento L, Cole PA, Medrano EE.
    Cancer Res; 2002 Nov 01; 62(21):6231-9. PubMed ID: 12414652
    [Abstract] [Full Text] [Related]

  • 12. AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity.
    Liu Y, Lu C, Shen Q, Munoz-Medellin D, Kim H, Brown PH.
    Oncogene; 2004 Oct 28; 23(50):8238-46. PubMed ID: 15378019
    [Abstract] [Full Text] [Related]

  • 13. Role of pRB-family/E2F complex in the inhibition of IL-3-dependent lymphoid cell proliferation.
    Yamada M, Kondo T, Ashizawa S, Takebayashi T, Higashi H, Hatakeyama M.
    Cytokine; 2002 Jan 21; 17(2):91-7. PubMed ID: 11886176
    [Abstract] [Full Text] [Related]

  • 14. Activity of E2F-dependent promoters in bladder carcinoma cells and their use for tumour-specific targeting of p53-induced apoptosis.
    Steinhoff C, Prior A, Reichmann G, Seifert HH, Schulz WA.
    Int J Oncol; 2002 Nov 21; 21(5):1033-40. PubMed ID: 12370752
    [Abstract] [Full Text] [Related]

  • 15. RB and RB2/p130 genes demonstrate both specific and overlapping functions during the early steps of in vitro neural differentiation of marrow stromal stem cells.
    Jori FP, Melone MA, Napolitano MA, Cipollaro M, Cascino A, Giordano A, Galderisi U.
    Cell Death Differ; 2005 Jan 21; 12(1):65-77. PubMed ID: 15459751
    [Abstract] [Full Text] [Related]

  • 16. IKK/NF-kappaB signaling pathway inhibits cell-cycle progression by a novel Rb-independent suppression system for E2F transcription factors.
    Araki K, Kawauchi K, Tanaka N.
    Oncogene; 2008 Sep 25; 27(43):5696-705. PubMed ID: 18542057
    [Abstract] [Full Text] [Related]

  • 17. BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways.
    Zhou J, Ma J, Zhang BC, Li XL, Shen SR, Zhu SG, Xiong W, Liu HY, Huang H, Zhou M, Li GY.
    J Cell Physiol; 2004 Jul 25; 200(1):89-98. PubMed ID: 15137061
    [Abstract] [Full Text] [Related]

  • 18. Engineered mutants of pRB with improved growth suppression potential.
    Antelman D, Perry S, Hollingsworth R, Gregory RJ, Driscoll B, Fung YK, Bookstein R.
    Oncogene; 1997 Dec 04; 15(23):2855-66. PubMed ID: 9419977
    [Abstract] [Full Text] [Related]

  • 19. Melanoma cell autonomous growth: the Rb/E2F pathway.
    Halaban R.
    Cancer Metastasis Rev; 1999 Dec 04; 18(3):333-43. PubMed ID: 10721488
    [Abstract] [Full Text] [Related]

  • 20. The tyrphostin AG1024 accelerates the degradation of phosphorylated forms of retinoblastoma protein (pRb) and restores pRb tumor suppressive function in melanoma cells.
    von Willebrand M, Zacksenhaus E, Cheng E, Glazer P, Halaban R.
    Cancer Res; 2003 Mar 15; 63(6):1420-9. PubMed ID: 12649208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.